Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17676050 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Glatiramer acetate

Study has passed its completion date and status has not been verified in more than two years.